Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (121-130 of 8,369) with videos related to

Pageof 837
Sort By:
Drugs|January 15, 2020
Zanubrutinib: First ApprovalYahiya Y Syed
Drugs|December 12, 2022
Correction to: Spesolimab: First ApprovalHannah A Blair
Drugs|June 14, 2023
Correction to: Lenacapavir: First ApprovalJulia Paik
Drugs|April 6, 2020
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast CancerConnie Kang, Yahiya Y Syed
Drugs|August 29, 2020
Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent ProgressAna M Giménez-Arnau, Andaç Salman
Drugs|January 1, 1988
Effects of training on the serum lipid profile in normal menP Hespel, P Lijnen, R Fagard, et al.
Drugs|March 25, 2020
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface PainHarrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, et al.
Drugs|January 1, 1988
Sulbactam/ampicillin in clinical practice. Proceedings of a symposium. Munich, 17 January 1987
Drugs|January 1, 1988
Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory diseaseD L Hemsell, M C Heard, P G Hemsell, et al.
Drugs|January 1, 1988
Clinical and pharmacokinetic studies of sulbactam/penicillin combinations in the treatment of ear, nose and throat infectionsP Federspil, M Schedler, P Kurt, et al.
Pageof 837

Showing results (121-130 of 8,369) with videos related to

Sort By:
Pageof 837
Drugs|January 15, 2020
Zanubrutinib: First ApprovalYahiya Y Syed
Drugs|December 12, 2022
Correction to: Spesolimab: First ApprovalHannah A Blair
Drugs|June 14, 2023
Correction to: Lenacapavir: First ApprovalJulia Paik
Drugs|April 6, 2020
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast CancerConnie Kang, Yahiya Y Syed
Drugs|August 29, 2020
Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent ProgressAna M Giménez-Arnau, Andaç Salman
Drugs|January 1, 1988
Effects of training on the serum lipid profile in normal menP Hespel, P Lijnen, R Fagard, et al.
Drugs|March 25, 2020
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface PainHarrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, et al.
Drugs|January 1, 1988
Sulbactam/ampicillin in clinical practice. Proceedings of a symposium. Munich, 17 January 1987
Drugs|January 1, 1988
Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory diseaseD L Hemsell, M C Heard, P G Hemsell, et al.
Drugs|January 1, 1988
Clinical and pharmacokinetic studies of sulbactam/penicillin combinations in the treatment of ear, nose and throat infectionsP Federspil, M Schedler, P Kurt, et al.
Pageof 837